Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The null syndrome is part of the Pelizaeus-Merzbacher disease (PMD) spectrum and is characterized by mild PMD features associated with demyelinating peripheral neuropathy.
Features include very common findings: Abnormality of peripheral nerve conduction, CNS hypomyelination, Demyelinating peripheral neuropathy, and Peripheral demyelination; and common findings: Decreased nerve conduction velocity, Ataxia, Difficulty walking (gait disturbance), and Progressive spastic paraplegia. 14 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Demyelinating peripheral neuropathy, Ataxia, Difficulty walking (gait disturbance) |
Phenotype severity distribution: 4 very common features, 4 common features.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
2 publications have been identified in PubMed for null syndrome. Kisho has analyzed 1 by research type. Research spans Basic Science / Preclinical (100%).
Miolo G (2024). [PMID: 38732303](https://pubmed.ncbi.nlm.nih.gov/38732303/). *Diagnostics (Basel)*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:29 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Eyes | 1 | Damage to the optic nerve (optic atrophy) |
Muscles | 1 | Damage to the optic nerve (optic atrophy) |